You searched for "dementia"
TAC testing in dementia
1 April 2014
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
The aim was to assess the visual acuity measurements performed by the preferential looking method using Teller acuity cards (TAC) in elderly subjects with dementia due to probable Alzheimer’s disease. The mean age was 78.2±9.11 years for patients and 77.2±6.19...
Screening for visual processing deficits in dementia
5 April 2022
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Dementia, cognitive impairment, screening test, visual deficits, visuospatial
The Queen Square Screening test for Visual Deficits (QS test) screens for changes in visual processing. It has never been formally validated as a single test. The test consists of a short booklet developed using remnant object and spatial perception...
Dementia and visual impairment: what is the relationship and are we providing the best care?
Carla Maden discusses the implications of living with both dementia and visual impairment, and how general medical junior doctors and ophthalmologists can help to alleviate this burden and improve the quality of life of such patients. Dementia and visual impairment...New initiative lifts barriers to cataract care for people with disabilities and dementia
24 February 2022
Picture books and personalised videos - SpaMedica rolls out scheme to benefit vulnerable NHS cataract patients across country
Optical Express sponsors Atlantic rowing challenge for dementia research
Optical Express has become the official headline sponsor of a rowing challenge that will see Jason Black (52) and Neil Glover (60) row over 3100 miles across the Atlantic Ocean, in an effort to raise money to fund groundbreaking research into a cure for dementia.
Age-related macular degeneration
1 December 2015
| Nana Theodorou
|
Retina / Uvea / Vitreous
This review article offers an up to date review of the genetic and environmental risk factors associated with aetiology surrounding age-related macular degeneration (AMD). The article briefly describes the typical clinical presentation relating to early and late stages of the...
insitro and UK’s INSIGHT at Moorfields Eye Hospital announce collaboration to expand research efforts in neurodegeneration and related conditions
The world’s largest bioresource of eye images offers window into human health and serves as basis of a new AI foundation model to boost drug discovery. insitro, a machine learning-enabled drug discovery and development company, and the INSIGHT Health Data...Can OCT predict Alzheimer’s disease?
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Can OCT predict Alzheimer’s disease? In 1986 Hinton et al. demonstrated evidence of optic nerve degeneration...Patient care a family affair at Newcastle-Under-Lyme eye hospital
14 March 2022
With Mother’s Day just around the corner, mother and daughter Lisa Moors and Hannah Young won’t have to wait until next Sunday to spend time together - the pair work side-by-side, caring for hundreds of cataract surgery patients each week...
Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions
1 August 2018
| Rod McNeil
|
EYE - General
Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...
Moorfields Education: Hot topics in comprehensive ophthalmology
7 February 2025
Hot topics in comprehensive ophthalmology is a course for people who work in the field suitable for comprehensive/general ophthalmologists, urgent care and primary care, optometrists and nurse practitioners. This is an update on common themes which appear in the comprehensive...
Test combination which could detect prodromal Alzheimer disease
2 August 2022
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors prospectively recruited a convenience sample of individuals aged over 65 and either with a diagnosis of mild cognitive impairment (MCI) due to Alzheimer disease or normal cognition. Other types of dementia and severe neurological conditions were excluded. All...
